NIAID

Dear Research Advocate, Budget conversations are back to the fore. President Trump has made it clear that his budget will cut non-defense discretionary (NDD) deeply. NDD makes up only about 16% of the federal budget, but fuels a wide range of crucial American priorities like education, criminal justice, services for veterans, public health, child protection and science. As Senator Lamar Alexander (R-TN) recently made clear cutting non-defense discretionary (NDD) funding is not a viable strategy for addressing our nation’s fiscal issues. We agree and challenge advocates for research to speak up for the role of science in stabilizing our fiscal future. On The Bio Report podcast today, I...
This article is the second in a series highlighting the accomplishments of Research!America’s 2017 Advocacy Award honorees who will be saluted at a dinner in Washington, D.C., on March 15. More details can be found here . Anthony S. Fauci, M.D., is Research!America’s recipient of the Legacy Award , which honors an individual’s outstanding commitment to sustaining our nation’s world-class leadership in medical and health research. Dr. Fauci is the director of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). An effective communicator, Dr. Fauci has testified before Congress more than 250 times, voicing strong support for biomedical...
The serendipitous discovery of penicillin by Alexander Fleming in 1928 transformed the course of modern medicine. Penicillin, followed by a series of other antibiotics, seemed to promise a world free of infectious diseases that once killed millions of people worldwide. Medical breakthroughs such as organ transplants and chemotherapy would not have been possible without the development of antimicrobials. Fleming warned, however, that microbes have the ability to, and inevitably will, develop resistance to antibiotics. It did not take long to prove him right, with drug-resistant strains appearing just within years after the introduction of penicillin, as was the case for many subsequent...
A recently published, unexpected discovery coming from researchers at Albert Einstein College of Medicine at Yeshiva University suggests that vitamin C may be a useful component to treating drug-resistant tuberculosis. This finding may sound more like something out of a television medical drama than real life, but the research €”funded by the National Institute for Allergy and Infectious Disease at the National Institutes of Health suggests that ascorbic acid may help kill the bacteria that cause TB. These preliminary findings have laid a foundation for clinical trials using vitamin C in tandem with other drugs. Researchers observed that vitamin C treatment of the cultured bacteria led to...
Research!America’s booth at GHTC briefing On February 26, the Global Health Technologies Coalition held a Capitol Hill briefing, ’€œ Renewing US leadership: Policies to advance global health research .’€ The briefing included displays from global health nonprofits, the launch of GHTC’€™s fourth annual policy report as well as a panel discussion. Panelists included Dr. Lee Hall, Chief of Parasitology and International Programs at NIAID, Dr. Alan Magill, Director of Malaria at the Gates Foundation and Dr. Caroline Ryan, Deputy Coordinator for Technical Leadership at PEPFAR. Each highlighted key U.S. contributions to global health including the development of a rapid TB diagnostic, advances...
This week, Boston Mayor Thomas M. Menino declared a public health emergency in the city due to a flu outbreak. City officials have confirmed 700 cases of the flu, nearly ten times the confirmed cases last year; four people have died so far. Outbreaks have been reported in other areas of the country, affecting individuals of all ages and backgrounds. The Centers for Disease Control and Prevention recommends that the best way to prevent the flu is by getting vaccinated each year. It’€™s hard to imagine the dire health consequences Americans would endure without the flu vaccine, which is due in part to federal investments in research. The CDC and the Food and Drug Administration have made...
On Friday, September 7, at the National Institutes of Health campus, the Trans-NIH Global Health Working Group hosted a lecture titled, ’€œRapid, automated diagnostics for tuberculosis: a potential new benchmark.’€ Mark Perkins, MD, who has worked at the Global Tuberculosis Programme of the World Health Organization and is currently the chief scientific officer at the Foundation for New Innovative Diagnostics (FIND), discussed the development of a new testing method for tuberculosis. Identified as the cause of death for 1.4 million individuals in 2010, including people in the United States , TB is a significant global health concern. However, it is consistently underdiagnosed due to...

Sidebar Quote

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco